IMUNON to Present Phase 3 Ovarian Cancer Study of IMNN-001 at ESMO Congress

Prestigious European Society for Medical Oncology Conference “trials-in-progress” sessionPivotal OVATION 3 trial of its DNA-mediated ...
Targeted Oncology

Long-Term OS Data Guide Use of PARP Inhibitors in Ovarian Cancer

Preventing relapse of advanced ovarian cancer with PARP inhibitors is now an established strategy. As data from pivotal ...

Woman Reveals 2 Big Symptoms Before 'Shock' Ovarian Cancer Diagnosis

Carla Peoples thought her symptoms were due to another problem, but was shocked to be diagnosed with ovarian cancer. She ...
Healio

No debate? Neoadjuvant chemotherapy reduces mortality in advanced ovarian cancer

Please provide your email address to receive an email when new articles are posted on . Neoadjuvant chemotherapy significantly lowered 90-day postoperative mortality for advanced ovarian cancer across ...

A new approach to study treatment resistance in high-grade serous ovarian cancer

Several factors make ovarian cancer particularly challenging to treat. This is largely because the cancer often spreads at a ...